TreeWAS – Variant ID: rs4788957

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability
Chapter X Diseases of the respiratory system	1.000	0.000
# Top node	1.000	0.000
Chapter VI Diseases of the nervous system	0.999	0.001
J40-J47 Chronic lower respiratory diseases	0.999	0.001
Chapter IV Endocrine, nutritional and metabolic diseases	0.998	0.002
J43 Emphysema	0.997	0.003
J09-J18 Influenza and pneumonia	0.996	0.004
E65-E68 Obesity and other hyperalimentation	0.994	0.006
J43.9 Emphysema, unspecified	0.993	0.007
E66 Obesity	0.992	0.008
J18 Pneumonia, organism unspecified	0.989	0.011
J80-J84 Other respiratory diseases principally affecting the interstitium	0.984	0.016
G90-G99 Other disorders of the nervous system	0.984	0.016
E66.9 Obesity, unspecified	0.984	0.016
Chapter VII Diseases of the eye and adnexa	0.971	0.029
Chapter I Certain infectious and parasitic diseases	0.965	0.035
J20-J22 Other acute lower respiratory infections	0.961	0.039
Chapter XX External causes of morbidity and mortality	0.957	0.043
J18.1 Lobar pneumonia, unspecified	0.952	0.048
Chapter II Neoplasms	0.950	0.050
G93 Other disorders of brain	0.945	0.055
J84 Other interstitial pulmonary diseases	0.941	0.059
J95-J99 Other diseases of the respiratory system	0.940	0.060
H49-H52 Disorders of ocular muscles, binocular movement, accommodation and refraction	0.940	0.060
Chapter IX Diseases of the circulatory system	0.935	0.065
I30-I52 Other forms of heart disease	0.933	0.067
J22 Unspecified acute lower respiratory infection	0.933	0.067
J18.9 Pneumonia, unspecified	0.932	0.068
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.927	0.073
I44 Atrioventricular and left bundle-branch block	0.927	0.073
E66.8 Other obesity	0.926	0.074
Chapter V Mental and behavioural disorders	0.914	0.086
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.906	0.094
J80 Adult respiratory distress syndrome	0.905	0.095
G20-G26 Extrapyramidal and movement disorders	0.900	0.100
B95-B98 Bacterial, viral and other infectious agents	0.898	0.102
Chapter XVII Congenital malformations, deformations and chromosomal abnormalities	0.897	0.103
Chapter XIX Injury, poisoning and certain other consequences of external causes	0.895	0.105
I49 Other cardiac arrhythmias	0.894	0.106
G80-G83 Cerebral palsy and other paralytic syndromes	0.894	0.106
I34 Nonrheumatic mitral valve disorders	0.893	0.107
H53-H54 Visual disturbances and blindness	0.892	0.108
J47 Bronchiectasis	0.891	0.109
J98 Other respiratory disorders	0.891	0.109
G60-G64 Polyneuropathies and other disorders of the peripheral nervous system	0.888	0.112
H55-H59 Other disorders of eye and adnexa	0.883	0.117
J84.1 Other interstitial pulmonary diseases with fibrosis	0.883	0.117
D10-D36 Benign neoplasms	0.868	0.132
I34.0 Mitral (valve) insufficiency	0.864	0.136
J43.2 Centrilobular emphysema	0.863	0.137
Chapter XXII Codes for special purposes	0.862	0.138
G40-G47 Episodic and paroxysmal disorders	0.861	0.139
J90-J94 Other diseases of pleura	0.860	0.140
I44.7 Left bundle-branch block, unspecified	0.860	0.140
I44.1 Atrioventricular block, second degree	0.858	0.142
H52 Disorders of refraction and accommodation	0.856	0.144
Y40 Systemic antibiotics	0.852	0.148
G30-G32 Other degenerative diseases of the nervous system	0.847	0.152
E00-E07 Disorders of thyroid gland	0.845	0.155
E10-E14 Diabetes mellitus	0.843	0.157
J60-J70 Lung diseases due to external agents	0.837	0.163
G62 Other polyneuropathies	0.837	0.163
F00-F09 Organic, including symptomatic, mental disorders	0.833	0.167
H53 Visual disturbances	0.828	0.172
I44.0 Atrioventricular block, first degree	0.827	0.173
I49.3 Ventricular premature depolarisation	0.827	0.173
C83 Diffuse non-Hodgkin's lymphoma	0.826	0.174
E20-E35 Disorders of other endocrine glands	0.823	0.177
G99 Other disorders of nervous system in diseases classified elsewhere	0.822	0.178
D32 Benign neoplasm of meninges	0.821	0.179
G81 Hemiplegia	0.818	0.182
S50-S59 Injuries to the elbow and forearm	0.815	0.185
J46 Status asthmaticus	0.815	0.185
F10-F19 Mental and behavioural disorders due to psychoactive substance use	0.814	0.186
B96 Other bacterial agents as the cause of diseases classified to other chapters	0.814	0.186
G20 Parkinson's disease	0.811	0.189
J18.0 Bronchopneumonia, unspecified	0.809	0.191
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.808	0.192
B95 Streptococcus and staphylococcus as the cause of diseases classified to other chapters	0.808	0.192
H49 Paralytic strabismus	0.807	0.193
J44 Other chronic obstructive pulmonary disease	0.806	0.194
G10-G14 Systemic atrophies primarily affecting the central nervous system	0.803	0.197
G93.3 Postviral fatigue syndrome	0.803	0.197
H50 Other strabismus	0.800	0.200
S30-S39 Injuries to the abdomen, lower back, lumbar spine and pelvis	0.798	0.202
J84.9 Interstitial pulmonary disease, unspecified	0.796	0.204
H25-H28 Disorders of lens	0.792	0.208
J10 Influenza due to identified influenza virus	0.790	0.210
H57 Other disorders of eye and adnexa	0.789	0.211
J42 Unspecified chronic bronchitis	0.788	0.212
J00-J06 Acute upper respiratory infections	0.788	0.212
G93.9 Disorder of brain, unspecified	0.787	0.213
J15 Bacterial pneumonia, not elsewhere classified	0.786	0.213
E14 Unspecified diabetes mellitus	0.785	0.215
E03 Other hypothyroidism	0.784	0.216
J98.0 Diseases of bronchus, not elsewhere classified	0.783	0.217
B15-B19 Viral hepatitis	0.782	0.218
X60-X84 Intentional self-harm	0.781	0.219
B95.6 Staphylococcus aureus as the cause of diseases classified to other chapters	0.781	0.219
G43 Migraine	0.778	0.222
J11 Influenza, virus not identified	0.774	0.226
D23 Other benign neoplasms of skin	0.773	0.227
W00-W19 Falls	0.773	0.227
J14 Pneumonia due to Haemophilus influenzae	0.772	0.228
G97 Postprocedural disorders of nervous system, not elsewhere classified	0.772	0.228
J90 Pleural effusion, not elsewhere classified	0.772	0.228
Chapter XIII Diseases of the musculoskeletal system and connective tissue	0.771	0.229
G96 Other disorders of central nervous system	0.771	0.229
D00-D09 In situ neoplasms	0.767	0.233
G93.0 Cerebral cysts	0.767	0.233
J98.1 Pulmonary collapse	0.766	0.234
A30-A49 Other bacterial diseases	0.764	0.236
H10-H13 Disorders of conjunctiva	0.764	0.236
G90 Disorders of autonomic nervous system	0.764	0.236
G81.9 Hemiplegia, unspecified	0.764	0.236
F05 Delirium, not induced by alcohol and other psychoactive substances	0.763	0.237
G93.6 Cerebral oedema	0.762	0.237
D37-D48 Neoplasms of uncertain or unknown behaviour	0.762	0.238
B96.1 Klebsiella pneumoniae [K. pneumoniae] as the cause of diseases classified to other chapters	0.762	0.238
G62.9 Polyneuropathy, unspecified	0.760	0.240
I95-I99 Other and unspecified disorders of the circulatory system	0.760	0.240
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.760	0.240
B35-B49 Mycoses	0.757	0.243
F17 Mental and behavioural disorders due to use of tobacco	0.757	0.243
Q20-Q28 Congenital malformations of the circulatory system	0.755	0.245
H15-H22 Disorders of sclera, cornea, iris and ciliary body	0.753	0.247
G93.8 Other specified disorders of brain	0.752	0.248
Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.751	0.249
B00-B09 Viral infections characterized by skin and mucous membrane lesions	0.750	0.250
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.749	0.251
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.748	0.252
D32.0 Cerebral meninges	0.748	0.252
J98.8 Other specified respiratory disorders	0.745	0.255
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites	0.744	0.256
M45-M49 Spondylopathies	0.743	0.257
T90-T98 Sequelae of injuries, of poisoning and of other consequences of external causes	0.743	0.257
B96.5 Pseudomonas (aeruginosa)(mallei)(pseudomallei) as the cause of diseases classified to other chapters	0.742	0.258
Y43 Primarily systemic agents	0.742	0.258
C43-C44 Melanoma and other malignant neoplasms of skin	0.741	0.259
E03.9 Hypothyroidism, unspecified	0.740	0.260
G00-G09 Inflammatory diseases of the central nervous system	0.737	0.263
J81 Pulmonary oedema	0.737	0.263
S80-S89 Injuries to the knee and lower leg	0.736	0.264
Y00-Y09 Assault	0.736	0.264
H52.0 Hypermetropia	0.734	0.266
G95 Other diseases of spinal cord	0.733	0.267
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.732	0.268
I47 Paroxysmal tachycardia	0.731	0.269
D18 Haemangioma and lymphangioma, any site	0.730	0.270
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use	0.729	0.271
I44.2 Atrioventricular block, complete	0.729	0.271
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.728	0.272
I31 Other diseases of pericardium	0.726	0.274
Y40.9 Systemic antibiotic, unspecified	0.723	0.277
J85-J86 Suppurative and necrotic conditions of lower respiratory tract	0.723	0.277
G62.8 Other specified polyneuropathies	0.723	0.277
S20-S29 Injuries to the thorax	0.722	0.278
Q50-Q56 Congenital malformations of genital organs	0.720	0.280
I30 Acute pericarditis	0.720	0.280
H52.1 Myopia	0.718	0.282
A00-A09 Intestinal infectious diseases	0.718	0.282
Chapter XVI Certain conditions originating in the perinatal period	0.717	0.283
G70-G73 Diseases of myoneural junction and muscle	0.716	0.283
J41 Simple and mucopurulent chronic bronchitis	0.716	0.284
E40-E46 Malnutrition	0.716	0.284
D32.9 Meninges, unspecified	0.715	0.285
S70-S79 Injuries to the hip and thigh	0.715	0.285
J43.8 Other emphysema	0.715	0.285
J43.1 Panlobular emphysema	0.715	0.285
J43.0 MacLeod's syndrome	0.715	0.285
H53.0 Amblyopia ex anopsia	0.715	0.285
Y51 Drugs primarily affecting the autonomic nervous system	0.714	0.286
H55 Nystagmus and other irregular eye movements	0.714	0.286
J17 Pneumonia in diseases classified elsewhere	0.714	0.286
J16 Pneumonia due to other infectious organisms, not elsewhere classified	0.714	0.286
J12 Viral pneumonia, not elsewhere classified	0.714	0.286
J09 Influenza due to certain identified influenza virus	0.714	0.286
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.713	0.287
E67 Other hyperalimentation	0.713	0.287
E68 Sequelae of hyperalimentation	0.713	0.287
E65 Localised adiposity	0.713	0.287
G31 Other degenerative diseases of nervous system, not elsewhere classified	0.713	0.287
F05.9 Delirium, unspecified	0.713	0.287
Y40.0 Penicillins	0.713	0.287
H53.8 Other visual disturbances	0.712	0.288
E66.2 Extreme obesity with alveolar hypoventilation	0.711	0.289
E66.1 Drug-induced obesity	0.711	0.289
E66.0 Obesity due to excess calories	0.711	0.289
S52 Fracture of forearm	0.711	0.289
J06 Acute upper respiratory infections of multiple and unspecified sites	0.711	0.289
G43.9 Migraine, unspecified	0.710	0.290
T36-T50 Poisoning by drugs, medicaments and biological substances	0.710	0.290
J18.8 Other pneumonia, organism unspecified	0.709	0.291
J18.2 Hypostatic pneumonia, unspecified	0.709	0.291
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs	0.709	0.291
D17 Benign lipomatous neoplasm	0.707	0.293
H26 Other cataract	0.707	0.293
J82 Pulmonary eosinophilia, not elsewhere classified	0.706	0.294
G99.2 Myelopathy in diseases classified elsewhere	0.706	0.294
G94 Other disorders of brain in diseases classified elsewhere	0.705	0.294
G98 Other disorders of nervous system, not elsewhere classified	0.705	0.294
G92 Toxic encephalopathy	0.705	0.294
X40-X49 Accidental poisoning by and exposure to noxious substances	0.705	0.295
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.704	0.295
J61 Pneumoconiosis due to asbestos and other mineral fibres	0.703	0.296
H46-H48 Disorders of optic nerve and visual pathways	0.703	0.297
G45 Transient cerebral ischaemic attacks and related syndromes	0.702	0.298
Y44 Agents primarily affecting blood constituents	0.701	0.299
I49.5 Sick sinus syndrome	0.700	0.300
H50.9 Strabismus, unspecified	0.700	0.300
G24 Dystonia	0.699	0.301
S30 Superficial injury of abdomen, lower back and pelvis	0.697	0.303
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.696	0.304
F17.1 Harmful use	0.695	0.305
D10 Benign neoplasm of mouth and pharynx	0.694	0.306
J99 Respiratory disorders in diseases classified elsewhere	0.694	0.306
D36 Benign neoplasm of other and unspecified sites	0.694	0.306
J95 Postprocedural respiratory disorders, not elsewhere classified	0.693	0.306
C83.1 Small cleaved cell (diffuse)	0.693	0.307
I38 Endocarditis, valve unspecified	0.693	0.307
I49.8 Other specified cardiac arrhythmias	0.693	0.307
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.692	0.307
E14.3 With ophthalmic complications	0.692	0.308
Q00-Q07 Congenital malformations of the nervous system	0.692	0.308
H49.0 Third [oculomotor] nerve palsy	0.692	0.308
B99-B99 Other infectious diseases	0.691	0.308
B90-B94 Sequelae of infectious and parasitic diseases	0.691	0.308
B85-B89 Pediculosis, acariasis and other infestations	0.691	0.308
B65-B83 Helminthiases	0.691	0.308
B50-B64 Protozoal diseases	0.691	0.308
B20-B24 Human immunodeficiency virus [HIV] disease	0.691	0.308
A92-A99 Arthropod-borne viral fevers and viral haemorrhagic fevers	0.691	0.308
A80-A89 Viral infections of the central nervous system	0.691	0.308
A75-A79 Rickettsioses	0.691	0.308
A70-A74 Other diseases caused by chlamydiae	0.691	0.308
A65-A69 Other spirochaetal diseases	0.691	0.308
A20-A28 Certain zoonotic bacterial diseases	0.691	0.308
A15-A19 Tuberculosis	0.691	0.308
J44.8 Other specified chronic obstructive pulmonary disease	0.691	0.309
I49.0 Ventricular fibrillation and flutter	0.690	0.310
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.689	0.311
J21 Acute bronchiolitis	0.689	0.311
J20 Acute bronchitis	0.689	0.311
F99-F99 Unspecified mental disorder	0.687	0.313
E14.9 Without complications	0.687	0.313
H57.8 Other specified disorders of eye and adnexa	0.687	0.313
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use	0.686	0.314
Y35-Y36 Legal intervention and operations of war	0.686	0.314
Y10-Y34 Event of undetermined intent	0.686	0.314
X85-X99 Assault	0.686	0.314
X58-X59 Accidental exposure to other and unspecified factors	0.686	0.314
X50-X57 Overexertion, travel and privation	0.686	0.314
X30-X39 Exposure to forces of nature	0.686	0.314
X20-X29 Contact with venomous animals and plants	0.686	0.314
X10-X19 Contact with heat and hot substances	0.686	0.314
X00-X09 Exposure to smoke, fire and flames	0.686	0.314
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure	0.686	0.314
W75-W84 Other accidental threats to breathing	0.686	0.314
W65-W74 Accidental drowning and submersion	0.686	0.314
W50-W64 Exposure to animate mechanical forces	0.686	0.314
V98-V99 Other and unspecified transport accidents	0.686	0.314
V95-V97 Air and space transport accidents	0.686	0.314
V90-V94 Water transport accidents	0.686	0.314
V80-V89 Other land transport accidents	0.686	0.314
V70-V79 Bus occupant injured in transport accident	0.686	0.314
V60-V69 Occupant of heavy transport vehicle injured in transport accident	0.686	0.314
V50-V59 Occupant of pick-up truck or van injured in transport accident	0.686	0.314
V40-V49 Car occupant injured in transport accident	0.686	0.314
V30-V39 Occupant of three-wheeled motor vehicle injured in transport accident	0.686	0.314
V01-V09 Pedestrian injured in transport accident	0.686	0.314
F03 Unspecified dementia	0.684	0.316
M45 Ankylosing spondylitis	0.684	0.316
Y60-Y69 Misadventures to patients during surgical and medical care	0.684	0.316
H53.4 Visual field defects	0.683	0.317
C97-C97 Malignant neoplasms of independent (primary) multiple sites	0.681	0.318
C40-C41 Malignant neoplasms of bone and articular cartilage	0.681	0.318
U82-U85 Resistance to antimicrobial and antineoplastic drugs	0.681	0.319
D65-D69 Coagulation defects, purpura and other haemorrhagic conditions	0.681	0.319
J44.1 Chronic obstructive pulmonary disease with acute exacerbation, unspecified	0.680	0.320
Y40.1 Cefalosporins and other -lactam antibiotics	0.679	0.321
G93.7 Reye's syndrome	0.678	0.322
G93.5 Compression of brain	0.678	0.322
G93.4 Encephalopathy, unspecified	0.678	0.322
G93.2 Benign intracranial hypertension	0.678	0.322
G93.1 Anoxic brain damage, not elsewhere classified	0.678	0.322
C79 Secondary malignant neoplasm of other sites	0.678	0.322
I49.1 Atrial premature depolarisation	0.675	0.325
J84.8 Other specified interstitial pulmonary diseases	0.674	0.326
J84.0 Alveolar and parietoalveolar conditions	0.674	0.326
J96 Respiratory failure, not elsewhere classified	0.674	0.326
I44.3 Other and unspecified atrioventricular block	0.674	0.326
Y83-Y84 Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure	0.674	0.326
H51 Other disorders of binocular movement	0.674	0.326
J13 Pneumonia due to Streptococcus pneumoniae	0.674	0.326
S10-S19 Injuries to the neck	0.673	0.327
D13 Benign neoplasm of other and ill-defined parts of digestive system	0.672	0.328
D34 Benign neoplasm of thyroid gland	0.672	0.328
Q65-Q79 Congenital malformations and deformations of the musculoskeletal system	0.672	0.328
H54 Blindness and low vision	0.671	0.328
D04 Carcinoma in situ of skin	0.671	0.329
I00-I02 Acute rheumatic fever	0.670	0.330
M46 Other inflammatory spondylopathies	0.670	0.330
I52 Other heart disorders in diseases classified elsewhere	0.669	0.331
I48 Atrial fibrillation and flutter	0.669	0.331
I43 Cardiomyopathy in diseases classified elsewhere	0.669	0.331
I41 Myocarditis in diseases classified elsewhere	0.669	0.331
I40 Acute myocarditis	0.669	0.331
I39 Endocarditis and heart valve disorders in diseases classified elsewhere	0.669	0.331
I37 Pulmonary valve disorders	0.669	0.331
I36 Nonrheumatic tricuspid valve disorders	0.669	0.331
I32 Pericarditis in diseases classified elsewhere	0.669	0.331
F11 Mental and behavioural disorders due to use of opioids	0.668	0.331
J30-J39 Other diseases of upper respiratory tract	0.668	0.332
Y59 Other and unspecified vaccines and biological substances	0.665	0.335
Y58 Bacterial vaccines	0.665	0.335
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.665	0.335
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.665	0.335
Y53 Agents primarily affecting the gastro-intestinal system	0.665	0.335
Y50 Central nervous system stimulants, not elsewhere classified	0.665	0.335
Y49 Psychotropic drugs, not elsewhere classified	0.665	0.335
Y48 Anaesthetics and therapeutic gases	0.665	0.335
Y47 Sedatives, hypnotics and antianxiety drugs	0.665	0.335
Y46 Antiepileptics and anti-Parkinsonism drugs	0.665	0.335
Y41 Other systemic anti-infectives and antiparasitics	0.665	0.335
I44.6 Other and unspecified fascicular block	0.665	0.335
I44.5 Left posterior fascicular block	0.665	0.335
I44.4 Left anterior fascicular block	0.665	0.335
S51 Open wound of forearm	0.663	0.337
Y52 Agents primarily affecting the cardiovascular system	0.661	0.339
I26-I28 Pulmonary heart disease and diseases of pulmonary circulation	0.660	0.340
E27 Other disorders of adrenal gland	0.660	0.340
S32 Fracture of lumbar spine and pelvis	0.660	0.340
D11 Benign neoplasm of major salivary glands	0.659	0.341
D23.6 Skin of upper limb, including shoulder	0.659	0.341
I05-I09 Chronic rheumatic heart diseases	0.658	0.342
A50-A64 Infections with a predominantly sexual mode of transmission	0.656	0.344
J06.9 Acute upper respiratory infection, unspecified	0.656	0.344
V20-V29 Motorcycle rider injured in transport accident	0.655	0.345
F90-F98 Behavioural and emotional disorders with onset usually occurring in childhood and adolescence	0.655	0.345
F70-F79 Mental retardation	0.655	0.345
F60-F69 Disorders of adult personality and behaviour	0.655	0.345
C81 Hodgkin's disease	0.655	0.345
X62 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified	0.655	0.345
C92 Myeloid leukaemia	0.654	0.345
T29-T32 Burns and corrosions of multiple and unspecified body regions	0.654	0.346
G91 Hydrocephalus	0.653	0.346
G30 Alzheimer's disease	0.653	0.346
H52.3 Anisometropia and aniseikonia	0.651	0.349
D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs	0.650	0.350
H53.9 Visual disturbance, unspecified	0.650	0.350
J94 Other pleural conditions	0.650	0.350
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.650	0.350
C95 Leukaemia of unspecified cell type	0.650	0.350
C94 Other leukaemias of specified cell type	0.650	0.350
C93 Monocytic leukaemia	0.650	0.350
C88 Malignant immunoproliferative diseases	0.650	0.350
C86 Other specified types of T/NK-cell lymphoma	0.650	0.350
C84 Peripheral and cutaneous T-cell lymphomas	0.650	0.350
H50.0 Convergent concomitant strabismus	0.650	0.350
B96.3 Haemophilus influenzae [H. influenzae] as the cause of diseases classified to other chapters	0.649	0.351
I49.9 Cardiac arrhythmia, unspecified	0.649	0.351
F20-F29 Schizophrenia, schizotypal and delusional disorders	0.649	0.351
Q60-Q64 Congenital malformations of the urinary system	0.648	0.352
E11 Non-insulin-dependent diabetes mellitus	0.648	0.352
J40 Bronchitis, not specified as acute or chronic	0.647	0.353
C44 Other malignant neoplasms of skin	0.647	0.353
F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors	0.647	0.353
Y57 Other and unspecified drugs and medicaments	0.646	0.354
C73-C75 Malignant neoplasms of thyroid and other endocrine glands	0.645	0.355
G23 Other degenerative diseases of basal ganglia	0.645	0.355
G21 Secondary Parkinsonism	0.645	0.355
G26 Extrapyramidal and movement disorders in diseases classified elsewhere	0.645	0.355
G22 Parkinsonism in diseases classified elsewhere	0.645	0.355
E06 Thyroiditis	0.644	0.356
H57.1 Ocular pain	0.644	0.356
Q90-Q99 Chromosomal abnormalities, not elsewhere classified	0.643	0.357
Q80-Q89 Other congenital malformations	0.643	0.357
Q35-Q37 Cleft lip and cleft palate	0.643	0.357
Q30-Q34 Congenital malformations of the respiratory system	0.643	0.357
Q10-Q18 Congenital malformations of eye, ear, face and neck	0.643	0.357
J10.1 Influenza with other respiratory manifestations, influenza virus identified	0.642	0.358
T33-T35 Frostbite	0.642	0.358
T26-T28 Burns and corrosions confined to eye and internal organs	0.642	0.358
T20-T25 Burns and corrosions of external body surface, specified by site	0.642	0.358
T08-T14 Injuries to unspecified part of trunk, limb or body region	0.642	0.358
T00-T07 Injuries involving multiple body regions	0.642	0.358
I49.4 Other and unspecified premature depolarisation	0.641	0.359
I49.2 Junctional premature depolarisation	0.641	0.359
T66-T78 Other and unspecified effects of external causes	0.641	0.359
G83 Other paralytic syndromes	0.641	0.359
G82 Paraplegia and tetraplegia	0.641	0.359
G80 Infantile cerebral palsy	0.641	0.359
D21 Other benign neoplasms of connective and other soft tissue	0.641	0.359
G25 Other extrapyramidal and movement disorders	0.640	0.360
I34.9 Nonrheumatic mitral valve disorder, unspecified	0.640	0.360
I34.8 Other nonrheumatic mitral valve disorders	0.640	0.360
I34.2 Nonrheumatic mitral (valve) stenosis	0.640	0.360
T51-T65 Toxic effects of substances chiefly nonmedicinal as to source	0.639	0.360
J98.9 Respiratory disorder, unspecified	0.639	0.361
J98.6 Disorders of diaphragm	0.639	0.361
J98.5 Diseases of mediastinum, not elsewhere classified	0.639	0.361
J98.3 Compensatory emphysema	0.639	0.361
J98.2 Interstitial emphysema	0.639	0.361
V10-V19 Pedal cyclist injured in transport accident	0.637	0.363
G60 Hereditary and idiopathic neuropathy	0.637	0.363
G64 Other disorders of peripheral nervous system	0.637	0.363
J15.2 Pneumonia due to staphylococcus	0.636	0.364
Q27 Other congenital malformations of peripheral vascular system	0.635	0.365
W07 Fall involving chair	0.635	0.365
F80-F89 Disorders of psychological development	0.635	0.365
B95.3 Streptococcus pneumoniae as the cause of diseases classified to other chapters	0.634	0.365
U80 Agent resistant to penicillin and related antibiotics	0.634	0.366
F12 Mental and behavioural disorders due to use of cannabinoids	0.634	0.366
H59 Postprocedural disorders of eye and adnexa, not elsewhere classified	0.633	0.367
H58 Other disorders of eye and adnexa in diseases classified elsewhere	0.633	0.367
H11 Other disorders of conjunctiva	0.633	0.367
J38 Diseases of vocal cords and larynx, not elsewhere classified	0.632	0.368
I34.1 Mitral (valve) prolapse	0.632	0.368
E23 Hypofunction and other disorders of pituitary gland	0.631	0.369
S89 Other and unspecified injuries of lower leg	0.631	0.369
J69 Pneumonitis due to solids and liquids	0.631	0.369
D18.0 Haemangioma, any site	0.630	0.370
Q38-Q45 Other congenital malformations of the digestive system	0.630	0.370
G11 Hereditary ataxia	0.630	0.370
G40 Epilepsy	0.630	0.370
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.628	0.371
J92 Pleural plaque	0.628	0.372
D26 Other benign neoplasms of uterus	0.626	0.373
D14 Benign neoplasm of middle ear and respiratory system	0.626	0.374
M60-M63 Disorders of muscles	0.625	0.375
S50 Superficial injury of forearm	0.625	0.375
D25 Leiomyoma of uterus	0.625	0.375
W18 Other fall on same level	0.624	0.376
C91 Lymphoid leukaemia	0.624	0.376
D31 Benign neoplasm of eye and adnexa	0.622	0.377
D30 Benign neoplasm of urinary organs	0.622	0.377
D29 Benign neoplasm of male genital organs	0.622	0.377
D28 Benign neoplasm of other and unspecified female genital organs	0.622	0.377
D20 Benign neoplasm of soft tissue of retroperitoneum and peritoneum	0.622	0.377
D19 Benign neoplasm of mesothelial tissue	0.622	0.377
D16 Benign neoplasm of bone and articular cartilage	0.622	0.377
D15 Benign neoplasm of other and unspecified intrathoracic organs	0.622	0.377
I47.1 Supraventricular tachycardia	0.622	0.378
D23.5 Skin of trunk	0.622	0.378
B44 Aspergillosis	0.621	0.379
J93 Pneumothorax	0.621	0.379
W20-W49 Exposure to inanimate mechanical forces	0.620	0.380
G97.8 Other postprocedural disorders of nervous system	0.620	0.380
G96.1 Disorders of meninges, not elsewhere classified	0.619	0.381
G12 Spinal muscular atrophy and related syndromes	0.618	0.382
M46.9 Inflammatory spondylopathy, unspecified	0.618	0.382
B25-B34 Other viral diseases	0.617	0.383
H49.2 Sixth [abducent] nerve palsy	0.617	0.383
G46 Vascular syndromes of brain in cerebrovascular diseases	0.617	0.383
G41 Status epilepticus	0.617	0.383
F17.2 Dependence syndrome	0.617	0.383
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.617	0.383
S90-S99 Injuries to the ankle and foot	0.616	0.384
D17.2 Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs	0.616	0.384
Y43.1 Antineoplastic antimetabolites	0.615	0.385
J11.1 Influenza with other respiratory manifestations, virus not identified	0.615	0.385
H52.7 Disorder of refraction, unspecified	0.614	0.386
H52.6 Other disorders of refraction	0.614	0.386
H52.5 Disorders of accommodation	0.614	0.386
H52.4 Presbyopia	0.614	0.386
I33 Acute and subacute endocarditis	0.614	0.386
D23.7 Skin of lower limb, including hip	0.613	0.387
B18 Chronic viral hepatitis	0.612	0.388
G45.9 Transient cerebral ischaemic attack, unspecified	0.612	0.388
Y40.8 Other systemic antibiotics	0.611	0.389
Y40.7 Antifungal antibiotics, systemically used	0.611	0.389
Y40.6 Rifamycins	0.611	0.389
Y40.5 Aminoglycosides	0.611	0.389
Y40.4 Tetracyclines	0.611	0.389
Y40.3 Macrolides	0.611	0.389
Y40.2 Chloramphenicol group	0.611	0.389
B15 Acute hepatitis A	0.611	0.389
S52.6 Fracture of lower end of both ulna and radius	0.611	0.389
D68 Other coagulation defects	0.611	0.389
T15-T19 Effects of foreign body entering through natural orifice	0.610	0.389
H52.2 Astigmatism	0.610	0.390
C44.6 Skin of upper limb, including shoulder	0.609	0.391
S30.9 Superficial injury of abdomen, lower back and pelvis, part unspecified	0.608	0.392
G32 Other degenerative disorders of nervous system in diseases classified elsewhere	0.608	0.392
E70-E90 Metabolic disorders	0.608	0.392
H26.2 Complicated cataract	0.607	0.393
C90 Multiple myeloma and malignant plasma cell neoplasms	0.607	0.393
G90.2 Horner's syndrome	0.607	0.393
F01 Vascular dementia	0.606	0.394
S80 Superficial injury of lower leg	0.606	0.394
E01 Iodine-deficiency-related thyroid disorders and allied conditions	0.606	0.394
E00 Congenital iodine-deficiency syndrome	0.606	0.394
E02 Subclinical iodine-deficiency hypothyroidism	0.606	0.394
A49 Bacterial infection of unspecified site	0.605	0.395
B07 Viral warts	0.605	0.395
E13 Other specified diabetes mellitus	0.604	0.396
E12 Malnutrition-related diabetes mellitus	0.604	0.396
H26.8 Other specified cataract	0.604	0.396
D27 Benign neoplasm of ovary	0.602	0.398
Chapter XII Diseases of the skin and subcutaneous tissue	0.601	0.399

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations